We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.54T
AUM Growth
+$136B
Cap. Flow
+$2.01B
Cap. Flow %
0.13%
Top 10 Hldgs %
21.19%
Holding
8,401
New
313
Increased
3,923
Reduced
2,951
Closed
306

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.39B
2
NVDA icon
NVIDIA
NVDA
+$2.32B
3
MSFT icon
Microsoft
MSFT
+$2.06B
4
AAPL icon
Apple
AAPL
+$1.62B
5
BND icon
Vanguard Total Bond Market
BND
+$1.51B

Sector Composition

Rank Sector Weight
1 Technology 22.47%
2 Financials 11.66%
3 Consumer Discretionary 8.63%
4 Communication Services 7.31%
5 Healthcare 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
5926
Karyopharm Therapeutics
KPTI
$169M
$108K ﹤0.01%
25,091
+14,668
+141% +$72K
AKYA
5927
DELISTED
Akoya BioSciences
AKYA
$108K ﹤0.01%
83,019
-30,679
-27% -$36.9K
CMBT
5928
CMB.TECH NV
CMBT
$4.38B
$107K ﹤0.01%
11,902
-55,150
-82% -$503K
LDSF icon
5929
First Trust Low Duration Strategic Focus ETF
LDSF
$162M
$107K ﹤0.01%
5,638
+5,637
+563,700% +$106K
APRE icon
5930
Aprea Therapeutics
APRE
$8.28M
$107K ﹤0.01%
63,331
+30,523
+93% +$52K
JSML icon
5931
Janus Henderson Small Cap Growth Alpha ETF
JSML
$370M
$107K ﹤0.01%
1,585
+1
+0.1% +$62
GLSI icon
5932
Greenwich LifeSciences
GLSI
$207M
$107K ﹤0.01%
11,766
+2,219
+23% +$21.1K
APLT
5933
DELISTED
Applied Therapeutics
APLT
$107K ﹤0.01%
342,636
-2,529,588
-88% -$979K
FAPR icon
5934
FT Vest US Equity Buffer ETF April
FAPR
$1.26B
$107K ﹤0.01%
2,526
-317
-11% -$12.9K
INNV icon
5935
InnovAge Holding
INNV
$1.5B
$106K ﹤0.01%
28,842
-1,704
-6% -$5.96K
SCLX icon
5936
Scilex Holding
SCLX
$53.7M
$106K ﹤0.01%
18,054
+8,486
+89% +$48K
LXP.PRC icon
5937
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$89.5M
$106K ﹤0.01%
2,287
+177
+8% +$8.12K
MRSN
5938
DELISTED
Mersana Therapeutics
MRSN
$106K ﹤0.01%
14,304
+2,019
+16% +$17.7K
GTEC icon
5939
Greenland Technologies Holding
GTEC
$14.7M
$106K ﹤0.01%
53,096
+41,090
+342% +$78.8K
MJ icon
5940
Amplify Alternative Harvest ETF
MJ
$103M
$106K ﹤0.01%
5,876
-219
-4% -$4.13K
QVMT
5941
Invesco S&P 500 Concentrated QVM ETF
QVMT
$129M
$106K ﹤0.01%
2,028
-759
-27% -$37.9K
FICS icon
5942
First Trust International Developed Capital Strength ETF
FICS
$214M
$105K ﹤0.01%
2,675
-501
-16% -$19.3K
CLSD
5943
DELISTED
Clearside Biomedical
CLSD
$105K ﹤0.01%
8,726
SECT icon
5944
Main Sector Rotation ETF
SECT
$2.74B
$105K ﹤0.01%
1,802
+350
+24% +$18.5K
GEOS icon
5945
Geospace Technologies
GEOS
$88.1M
$104K ﹤0.01%
7,314
-10,711
-59% -$79.9K
JBBB icon
5946
Janus Henderson B-BBB CLO ETF
JBBB
$1.4B
$104K ﹤0.01%
2,163
-1,213,368
-100% -$58.3M
GFEB icon
5947
FT Vest US Equity Moderate Buffer ETF February
GFEB
$378M
$104K ﹤0.01%
+2,673
New +$99.5K
UTES icon
5948
Virtus Reaves Utilities ETF
UTES
$1.36B
$104K ﹤0.01%
1,377
+1,070
+349% +$74.3K
SDVD icon
5949
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
$901M
$104K ﹤0.01%
5,076
+107
+2% +$2.11K
VIGL
5950
DELISTED
Vigil Neuroscience
VIGL
$104K ﹤0.01%
13,091
-87,074
-87% -$390K

Similar funds

Morgan Stanley's Q2 2025 Portfolio in Review

As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
  • Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
  • Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
  • Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
  • Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
  • Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.